Sorrento Therapeutics
SRNEQ
$0.03000
Share price
3.45%
Change (1 day)
-85.00%
Change (1 year)
Categories
Sorrento Therapeutics (SRNEQ) - Total debt
Total debt on the balance sheet as of June 2023 : $0.20 B
According to Sorrento Therapeutics 's latest financial reports the company's total debt is $0.20 B. A company’s total debt is the sum of all current and non-current debts.
Sorrento Therapeutics - Total debt on balance sheet (from 2004 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.13 B | -43.39% |
| 2021-12-31 | $0.23 B | 40.25% |
| 2020-12-31 | $0.16 B | -41.75% |
| 2019-12-31 | $0.29 B | 24.65% |
| 2018-12-31 | $0.23 B | 4376.8% |
| 2017-12-31 | $5.21 M | -88.99% |
| 2016-12-31 | $47.31 M | 412.69% |
| 2015-12-31 | $9.22 M | -24.02% |
| 2014-12-31 | $12.14 M | 152.78% |
| 2013-12-31 | $4.8 M | |
| 2004-12-31 | $0 M | 0% |
| 2003-12-31 | $0 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Karyopharm Therapeutics
KPTI | $0.17 B | -14.73% | 🇺🇸 USA |
 Exelixis EXEL | $0.20 B | -2.95% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |